Drug Type Biosimilar, Monoclonal antibody |
Synonyms IBPM 005IX, IBPM005IX |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AS | Preclinical | IN | - | |
Arthritis, Psoriatic | Preclinical | IN | - | |
Crohn Disease | Preclinical | IN | - | |
Juvenile Idiopathic Arthritis | Preclinical | IN | - | |
Rheumatoid Arthritis | Preclinical | IN | - |